Binding specificities of the Tandab (CD3/CD19) were shown by flow cytometry analysis on a number of different CD19-positive B cell lymphoma cell lines, including Raji, Daudi, and BJAB, and CD3-positive Jurkat cells. This evidence concerns the gene CD19 and B-cell non-Hodgkin lymphoma.